These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 28779709)
1. Magnolol suppresses the proliferation and invasion of cholangiocarcinoma cells via inhibiting the NF-κB signaling pathway. Zhang FH; Ren HY; Shen JX; Zhang XY; Ye HM; Shen DY Biomed Pharmacother; 2017 Oct; 94():474-480. PubMed ID: 28779709 [TBL] [Abstract][Full Text] [Related]
2. Suppression of PKCδ/NF-κB Signaling and Apoptosis Induction through Extrinsic/Intrinsic Pathways Are Associated Magnolol-Inhibited Tumor Progression in Colorectal Cancer In Vitro and In Vivo. Su CM; Weng YS; Kuan LY; Chen JH; Hsu FT Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32429376 [TBL] [Abstract][Full Text] [Related]
3. Allicin Inhibits Proliferation and Invasion in Vitro and in Vivo via SHP-1-Mediated STAT3 Signaling in Cholangiocarcinoma. Chen H; Zhu B; Zhao L; Liu Y; Zhao F; Feng J; Jin Y; Sun J; Geng R; Wei Y Cell Physiol Biochem; 2018; 47(2):641-653. PubMed ID: 29794468 [TBL] [Abstract][Full Text] [Related]
4. Signaling pathway for TNF-alpha-induced MMP-9 expression: mediation through p38 MAP kinase, and inhibition by anti-cancer molecule magnolol in human urinary bladder cancer 5637 cells. Lee SJ; Park SS; Lee US; Kim WJ; Moon SK Int Immunopharmacol; 2008 Dec; 8(13-14):1821-6. PubMed ID: 18801463 [TBL] [Abstract][Full Text] [Related]
5. Magnolol suppressed cell migration and invasion and induced cell apoptosis via inhibition of the NF-κB signaling pathway by upregulating microRNA-129 in multiple myeloma. Jin W; Wang X; Zeng Y; Lan Y; Wang X Neoplasma; 2021 Mar; 68(2):404-415. PubMed ID: 33440989 [TBL] [Abstract][Full Text] [Related]
6. Magnolol suppresses NF-kappaB activation and NF-kappaB regulated gene expression through inhibition of IkappaB kinase activation. Tse AK; Wan CK; Zhu GY; Shen XL; Cheung HY; Yang M; Fong WF Mol Immunol; 2007 Apr; 44(10):2647-58. PubMed ID: 17240450 [TBL] [Abstract][Full Text] [Related]
7. Magnolol inhibits lipopolysaccharide-induced inflammatory response by interfering with TLR4 mediated NF-κB and MAPKs signaling pathways. Fu Y; Liu B; Zhang N; Liu Z; Liang D; Li F; Cao Y; Feng X; Zhang X; Yang Z J Ethnopharmacol; 2013 Jan; 145(1):193-9. PubMed ID: 23127653 [TBL] [Abstract][Full Text] [Related]
8. Mycoepoxydiene induces apoptosis and inhibits TPA-induced invasion in human cholangiocarcinoma cells via blocking NF-κB pathway. Li W; Li M; Su X; Qin L; Miao M; Yu C; Shen Y; Luo Q; Chen Q Biochimie; 2014 Jun; 101():183-91. PubMed ID: 24486723 [TBL] [Abstract][Full Text] [Related]
9. Magnolol attenuates neointima formation by inducing cell cycle arrest via inhibition of ERK1/2 and NF-kappaB activation in vascular smooth muscle cells. Karki R; Ho OM; Kim DW Biochim Biophys Acta; 2013 Mar; 1830(3):2619-28. PubMed ID: 23274740 [TBL] [Abstract][Full Text] [Related]
10. Magnolol Inhibits the Growth of Non-Small Cell Lung Cancer via Inhibiting Microtubule Polymerization. Shen J; Ma H; Zhang T; Liu H; Yu L; Li G; Li H; Hu M Cell Physiol Biochem; 2017; 42(5):1789-1801. PubMed ID: 28746938 [TBL] [Abstract][Full Text] [Related]
11. Apoptosis induction and ERK/NF-κB inactivation are associated with magnolol-inhibited tumor progression in hepatocellular carcinoma in vivo. Tsai JJ; Chen JH; Chen CH; Chung JG; Hsu FT Environ Toxicol; 2020 Feb; 35(2):167-175. PubMed ID: 31714653 [TBL] [Abstract][Full Text] [Related]
12. EF24 inhibits tumor growth and metastasis via suppressing NF-kappaB dependent pathways in human cholangiocarcinoma. Yin DL; Liang YJ; Zheng TS; Song RP; Wang JB; Sun BS; Pan SH; Qu LD; Liu JR; Jiang HC; Liu LX Sci Rep; 2016 Aug; 6():32167. PubMed ID: 27571770 [TBL] [Abstract][Full Text] [Related]
13. The effect of magnolol on the Toll-like receptor 4/nuclear factor κB signaling pathway in lipopolysaccharide-induced acute lung injury in mice. Yunhe F; Bo L; Xiaosheng F; Fengyang L; Dejie L; Zhicheng L; Depeng L; Yongguo C; Xichen Z; Naisheng Z; Zhengtao Y Eur J Pharmacol; 2012 Aug; 689(1-3):255-61. PubMed ID: 22683864 [TBL] [Abstract][Full Text] [Related]
14. Wnt/β-catenin signaling mediates the antitumor activity of magnolol in colorectal cancer cells. Kang YJ; Park HJ; Chung HJ; Min HY; Park EJ; Lee MA; Shin Y; Lee SK Mol Pharmacol; 2012 Aug; 82(2):168-77. PubMed ID: 22550094 [TBL] [Abstract][Full Text] [Related]
15. Anticancer potential of magnolol for lung cancer treatment. Seo JU; Kim MH; Kim HM; Jeong HJ Arch Pharm Res; 2011 Apr; 34(4):625-33. PubMed ID: 21544728 [TBL] [Abstract][Full Text] [Related]
16. Rhinacanthin-C Extracted from Rhinacanthus nasutus (L.) Inhibits Cholangiocarcinoma Cell Migration and Invasion by Decreasing MMP-2, uPA, FAK and MAPK Pathways. Boueroy P; Saensa‑Ard S; Siripong P; Kanthawong S; Hahnvajanawong C Asian Pac J Cancer Prev; 2018 Dec; 19(12):3605-3613. PubMed ID: 30583689 [TBL] [Abstract][Full Text] [Related]
17. Magnolol Induces Apoptosis and Inhibits ERK-modulated Metastatic Potential in Hepatocellular Carcinoma Cells. Kuan LY; Chen WL; Chen JH; Hsu FT; Liu TT; Chen WT; Wang KL; Chen WC; Liu YC; Wang WS In Vivo; 2018; 32(6):1361-1368. PubMed ID: 30348689 [TBL] [Abstract][Full Text] [Related]
18. Inhibitory role of magnolol on proliferative capacity and matrix metalloproteinase-9 expression in TNF-alpha-induced vascular smooth muscle cells. Kim HM; Bae SJ; Kim DW; Kim BK; Lee SB; Lee US; Kim CH; Moon SK Int Immunopharmacol; 2007 Aug; 7(8):1083-91. PubMed ID: 17570325 [TBL] [Abstract][Full Text] [Related]
19. Metformin Exerts Antiproliferative and Anti-metastatic Effects Against Cholangiocarcinoma Cells by Targeting STAT3 and NF-ĸB. Saengboonmee C; Seubwai W; Cha'on U; Sawanyawisuth K; Wongkham S; Wongkham C Anticancer Res; 2017 Jan; 37(1):115-123. PubMed ID: 28011481 [TBL] [Abstract][Full Text] [Related]
20. The natural compound magnolol inhibits invasion and exhibits potential in human breast cancer therapy. Liu Y; Cao W; Zhang B; Liu YQ; Wang ZY; Wu YP; Yu XJ; Zhang XD; Ming PH; Zhou GB; Huang L Sci Rep; 2013 Nov; 3():3098. PubMed ID: 24226295 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]